CER Daily Newsfeed

The Comparative Effectiveness Research Daily Newsfeed®, known for short as the CER Daily Newsfeed®, offers the latest news, research and related information on comparative effectiveness research, real-world data and evidence, value assessment and other important health care topics. 

News from Thursday, February 5, 2026

Articles

Medical Care Supplement Highlights the Capacity of PCORnet® to Power Patient-Centered Research

(2/5, PCORnet Blog) comments “...Titled, ‘Accelerating Patient-Centered Comparative Clinical Effectiveness Research: A Special Article Collection in Medical Care,’ the supplement offers an in-depth look at how the PCORnet infrastructure supports patient-centered health research, drives innovation, and enables high-impact research at a national scale. The supplement features 19 peer-reviewed, open-access articles that highlight the strong scientific value of PCORnet in advancing patient-centered health research. Together, the articles introduce the PCORnet infrastructure, trace the network’s growth over the past decade, showcase inspiring examples of research powered by PCORnet®, explore innovative approaches to engagement and partnership, and share insights from PCORnet® Network Partners on implementing new technologies.” Full

 

Next Up for Congress: Pharma Execs.

(2/4, Megan R. Wilson, The Washington Post) reports “...The House is turning its attention to the pharmaceutical industry as it tackles the issue of health care affordability in an election year - calling executives to testify about the ‘root’ causes of drug prices next Wednesday. It follows a hearing last month where lawmakers grilled the CEOs of the nation's top health insurance companies.” Subscription Required

Journals

Nivolumab plus Ipilimumab Versus Lenvatinib or Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis

Jiefeng Luo PhD, et al.

February 1, 2026, Cancer

Wiley

 

Lower Extremity Complications in Adults with Type 2 Diabetes Treated with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP4 Inhibitors, and Sulfonylureas: An Emulated Target Trial

Rozalina G McCoy, et al.

February 2, 2026, Endocrine Practice

PubMed 

 

Comparative Effectiveness of Biologics in Lung Function Improvement among Patients with Severe Asthma: A Real-World Study

Arnaud Bourdin, et al.

February 4, 2026, Respiratory Research

PubMed

 

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder

Joao Vitor Mahler, et al.

March 2026, Neurology, Neuroimmunology & Neuroinflammation

PubMed